2-(4-amino-3-bromo-5-fluoro-phenyl)-2-(isopropylamino)ethanol hydrochloride

ID: ALA5203966

Chembl Id: CHEMBL5203966

PubChem CID: 141286039

Max Phase: Preclinical

Molecular Formula: C11H17BrClFN2O

Molecular Weight: 291.16

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)NC(CO)c1cc(F)c(N)c(Br)c1.Cl

Standard InChI:  InChI=1S/C11H16BrFN2O.ClH/c1-6(2)15-10(5-16)7-3-8(12)11(14)9(13)4-7;/h3-4,6,10,15-16H,5,14H2,1-2H3;1H

Standard InChI Key:  HRRHOLKXQBVSHK-UHFFFAOYSA-N

Associated Targets(Human)

ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trachea (112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 291.16Molecular Weight (Monoisotopic): 290.0430AlogP: 2.20#Rotatable Bonds: 4
Polar Surface Area: 58.28Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.78CX LogP: 1.76CX LogD: 0.36
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.75Np Likeness Score: -0.65

References

1. Xing G, Li D, Woo AY, Zhi Z, Ji L, Xing R, Lv H, He B, An H, Zhao H, Lin B, Pan L, Cheng M..  (2022)  Discovery of a Highly Selective β2-Adrenoceptor Agonist with a 2-Amino-2-phenylethanol Scaffold as an Oral Antiasthmatic Agent.,  65  (7.0): [PMID:35360904] [10.1021/acs.jmedchem.1c02006]

Source